North China Pharmaceutical Company Inventory

North China Pharmaceutical Company (600812.SS) currently reports a inventory of $2.5B as of June 2026. That compares with $2.3B in the prior-year period — up 6.7% year over year. Use the charts on this page to explore North China Pharmaceutical Company's inventory history and peer comparisons.

North China Pharmaceutical Company's inventory increased from $2.3B to $2.5B — a 6.7% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

North China Pharmaceutical Company reported $2.5B in inventory as of June 2026. That compares with $2.3B in the prior-year period — up 6.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $2.5B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for North China Pharmaceutical Company, and consider following 600812.SS for alerts when major investors trade the stock.